HMS Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,130
Closed -$889K 113
2024
Q4
$889K Sell
11,130
-833
-7% -$72.1K 0.43% 47
2024
Q3
$1.08M Buy
11,963
+1,203
+11% +$101K 0.53% 47
2024
Q2
$847K Buy
10,760
+596
+6% +$48.9K 0.44% 47
2024
Q1
$886K Sell
10,164
-290
-3% -$24.8K 0.49% 47
2023
Q4
$861K Sell
10,454
-4,279
-29% -$326K 0.53% 44
2023
Q3
$1.15M Buy
14,733
+1,656
+13% +$139K 0.76% 37
2023
Q2
$1.15M Buy
+13,077
New +$1.13M 0.7% 40

Other funds holding MDT

HMS Capital Management's MDT Position: Q1 2025 in Review

HMS Capital Management sold out of Medtronic (MDT) in Q1 2025, closing a stake of 11,130 shares — an estimated $889K sold.

HMS Capital Management first reported a position in MDT in Q2 2023 and held it in 7 quarters. The position peaked at $1.15M in Q3 2023. 2,170 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • HMS Capital Management reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
  • HMS Capital Management sold 11,130 Medtronic shares in Q1 2025, an estimated $889K.
  • HMS Capital Management first reported a position in Medtronic in Q2 2023 and held it in 7 quarters.
  • HMS Capital Management's Medtronic position peaked at $1.15M in Q3 2023.
  • 2,170 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on HMS Capital Management's 13F filing for Q1 2025, filed 14 May 2025.